Utah State University

DigitalCommons@USU
Utah State University COVID-19 Oral History
Collection

Utah State University Special Collections &
Archives

12-1-2022

Interview with Valerie Crowley
Utah State University Special Collections & Archives

Follow this and additional works at: https://digitalcommons.usu.edu/covid

Recommended Citation
Utah State University Special Collections & Archives, "Interview with Valerie Crowley" (2022). Utah State
University COVID-19 Oral History Collection. 26.
https://digitalcommons.usu.edu/covid/26

This Book is brought to you for free and open access by
the Utah State University Special Collections & Archives
at DigitalCommons@USU. It has been accepted for
inclusion in Utah State University COVID-19 Oral History
Collection by an authorized administrator of
DigitalCommons@USU. For more information, please
contact digitalcommons@usu.edu.

USU COVID-19 2022 Oral History
TRANSCRIPTION COVER SHEET
Interviewee(s):

Dr. Valerie Crowley

Place of interview:
Date of interview:

Zoom Meeting
March 28, 2022

Interviewer(s):
Recordist:
Photographer:

Todd Welch, Tameron Williams
Tameron Williams

Recording equipment: Zoom Conferencing Software
Transcription equipment: NCH Express Scribe Transcription Software with Power Player foot pedal.
Transcribed by/date: Pioneer Transcription Services/Connie Landsford/13 June 2022
Transcript proofed by/date: Valerie Crowley/10 October 2022
Brief description of interview: Oral history interview with Dr. Valerie Crowley who oversaw the Utah
Veterinarian Diagnostic Laboratory’s COVID testing at Utah State University. In this role Crowley spun
up testing very quickly in an effort to meet the demands of many students, faculty, and staff who could
not get tested or whose testing took an unreasonable length of time to prevent further infection.
References:

TW:
Todd Welch
VC:
Valerie Crowley
TGRW: Tameron Gentry Raines Williams

NOTE: Interjections during pauses, transitions in dialogue (such as “umm”), and false starts and stops in
conversations are not included in transcribed. All additions to transcript noted with brackets.
TRANSCRIPTION

[00:01]
TW:

Today is Monday, March 28th, 2022. My name is Todd Welch from the Merrill-Cazier Library
Special Collections and Archives. This morning I am interviewing Dr. Valerie Crowley, a former
infectious disease specialist for the Utah Veterinarian Diagnostic Laboratory at Utah State
University. This is another oral history interview for the Covid Collection Project. Joining us on
this interview is Tameron Williams, the Covid Collection graduate intern.
Good morning, Dr. Crowley.

VC:

Hi. Good morning, both of you.

TW:

So, when did you start your career at Utah State University?

VC:

So I am from Toronto, Canada. And my husband and I moved to Logan in August of 2017. So we
moved there because he’s an academic and he got an assistant professorship in the Department of
Watershed Sciences. And we decided, “Let’s just move to Utah.” So we moved to Utah. We took
a bit of a leap. I sort of quit my job here – not quit it, but I sort of held onto it sort of at a distance.
And then we just set up shop in Logan, Utah. Took a big road trip to get there. We took about six-
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week road trip from Toronto, drove ourselves to Utah, all the way up to Vancouver, Canada, and
back again down to Utah. So we made a good trip out of it.

TW:

Great. And so, did you start in a particular position at Utah State University? Or did you start
right at the Utah Veterinarian Diagnostic?

VC:

No, it was – it all came – so, no, I did not. So I started – I needed to look for work, and so I got a
job in the Chemistry and Biochemistry Department working as a post-doctoral researcher with
Ryan Jackson in that department. And he works on CRISPR systems, which is not something that
I knew very much about. But I’m a molecular biologist by training, and so it was a very
molecular-heavy type of lab.

[01:55]
So I reached out to him, and, luckily, he gave me a job. And I worked there for about two years,
and then I decided to change a little bit, because I’d been doing something similar for a long time.
And then I worked at what is now called the Human Research Protection Program in the Office of
Research. So it used to be the IRB, so it’s where you review protocols doing human research.
And then it’s then – that’s when the pandemic hit. And I listened to one of these messages from
Noelle Cockett about – they were going to do testing on campus.
And, as a nuclear biologist, I’ve worked historically with malaria, and doing this type of testing is
something I could do with my eyes closed – I’ve done so much of it in my life. I wasn’t using it
actively then, but it’s a very, very traditional standard molecular biology technique. And I sent a
generic email to the UVDL generic email site, saying, “I know how to do this stuff if you need
any help.” And, luckily, Marcia, who is an administrative person at the UVDL, passed that on to
the director, Tom Baldwin, and then he gave me a call. And that’s where it all started.
TW:

So what timeframe are we talking about, the Noelle Cockett? Was it in the spring semester of –

VC:

No, this was August I heard this. So we were working from home. Things were slow on my
jobsite at the time, because it was human research, and all of that had been stopped because of the
pandemic. And I think it would have been some sort of address in August. And they were
planning to do it for that school year, for that academic year, which would have been starting that
month. I think I’ve got the time.
It’s either – actually, maybe I heard this in July. No, August. I was hired in August. And so I just
assumed that everything was in place, you know, like they had it all going. It was all going to go.
But then it turned out they didn’t have anybody to run it because the federal regulations are quite
strict with who is allowed to do this type of thing. And, even in the pandemic, even though the
school was fully staffed with a whole bunch of really solidly trained veterinarians, they won’t let
the vets touch any human samples.

[04:03]
And so, basically, the only criteria I needed to fit with the molecular biologists that have worked
with human samples before, and that was really the gateway. The only reason why I could take
this job is because I had the same background as all the vets there in terms of molecular stuff, but
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I had worked with human samples. So that was sort of the ticket that they needed to fill, and I
happened to have that requirement, like that experience.
TW:

Okay. So I don’t know if you can answer this question. I’m going to ask it anyway. But before the
COVID outbreak, obviously there wasn’t COVID testing at lab. But what were the scope of
services and the work that you performed at the vet lab?

VC:

So they did exclusively – so pre-pandemic, what I can really say is that they did animal diagnostic
testing. So it wasn’t a place where you take your animal that’s alive, really, like to the
veterinarian. It’s where the veterinarian sends samples or the bodies of animals, from either pets
or farms, and they diagnose what is, you know, wrong with them. They have a variety of different
services, so molecular pathology, regular pathology, necropsies. That’s sort of the work that they
do there. Hm-hmm.

TW:

And so they have a lot of the equipment that you possibly needed to conduct the COVID testing?

VC:

They did. So we needed to actually borrow quite a bit from – like scavenge equipment from the
whole university. There was a big, you know, sort of banding together of people sending emails
out requesting basically agents and equipment. And so they did have equipment at the vet lab that
we could use. But they had to run their own things.

[05:42]
And so I feel like we were the human COVID testing side. We were really like interlopers and
like trying unfortunately to take over their space, which we had to be very respectful that they had
their own jobs to do. So we set up really parallel services. So, at the beginning, the idea was to
use some of the equipment that they had if we had to. But we were able to scrounge between – on
the Logan campus and even at some of the other campuses for their cells, we could get all the
equipment we needed, actually. So we didn’t have to interfere too much with their regular
services.
TW:

And did they dedicate a space for you to set up your lab?

VC:

They did. They kicked out somebody, unfortunately. So a doctor – and that’s the virologist who
was working very much on SARS-CoV-2. So Dr. Bart Tarbet had a virology lab there. But he had
another lab at another place, and so he graciously sort of gave up that lab space somewhat
temporarily, which I think is still being used for human COVID testing even now.
But it’s his lab space that he sort of gave up. But since it wasn’t sort of preplanned, we actually
used lab space all over the facility. So we had one main lab, but then we had to use – pretty much
go into lots of other labs at the veterinary diagnostic lab to finish the procedure. So we were like
up in everybody’s face all the time. [Laughs]

TW:

And what was the size of your team that initial fall of 2020?

VC:

So we had – we were very lucky that we had four testing technicians. So they are the people who
were actually running the tests, so there were four of them. They were really – the reason I think
that it worked so well is they were too qualified for this type of work. They were really highly
qualified. And then we had two couriers.

[07:33]
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So it sounds quite simple to take things from the football stadium over to the vet lab, but it’s
really hard to get people to do that. And, when you’re busy, you can’t just easily run over and get
them. So then we had two couriers that they managed to find that were dedicated to just bringing
us samples twice a day. So even such simple task like that becomes very complicated to organize.
But we had two undergrads do that for us.
TW:

And were there any supply chain issues with being able to get testing equipment or swabs and
stuff that we’ve always heard that –

VC:

Yes, yes, it was incredibly difficult. So the federal guidelines outline how the procedure should be
done to a very – very particular level, even in terms of what kind of tips you can use to actually
transfer samples. You know, you see people in the lab with pipettes transferring samples from
tubes to tubes. Those use disposable tips on the end of them. They were requiring that they use a
very special type that has a filter on it. These are usually more expensive, and they’re always – I
mean, they were usually readily available. And so you had a pandemic, and everybody in the
world wants them.
So we also scrounged around the whole university, borrowing pipette tips from every single lab
and from some of the labs on the southern campuses. And Dr. Kerry Rood from the Veterinary
Department was in touch with people in Salt Lake City at this like FEMA warehouse. So he
would make all these runs down to Salt Lake City trying to get things like swabs, tubes, tips. And
the complication with that is, when you have this sort of hodgepodge of stuff, you have to
validate all the stuff that you have to show that it works properly.

[09:20]
So we had to do so much background validation just to keep things running with the stuff we had.
So every single time you had a different type of tip or tube, you had to verify that that worked. So
that – I think a lot of people don’t realize you have to do that. So that adds so much backend work
just to be able to use the stuff you’ve got. And then you would call companies and they would
promise you that they would get you stuff when you bought it, and then they wouldn’t send it.
So it’s, “Yes, yes, we have that in stock.” But they didn’t have them in stock, and they didn’t send
them to us. So we luckily had stuff, but it was because we scrounged around, like we – the USU
is doing quite a bit of research now, and so they had stuff to lend. And I had to make a list of all
the stuff we borrowed to return stuff, because people have small grants, right? If you only have a
$10,000 grant and you gave me $1,000 worth of your stuff, hm-hmm.
TW:

So how many tests were you actually capable of running on any given day with those kinds of
facts?

VC:

So we could very readily run 500 to 800 a day. We never really got to that point. We had quite a
bit of equipment to do that. But I think the highest peak, which would have been around
Christmas, about Thanksgiving, Christmastime 2020, we were doing about 600 a day, I think.

TW:

And the positivity rate? I mean, I’ve heard it ebbed and flowed, but –

VC:

Yes, but at that peak time, it was over 30%. It was wild, hm-hmm. And this whole time, actually,
I was pregnant. So I had my first child in December of 2020 and took this job on in August when
I must have been five months pregnant. So it was crazy. [Laughs]
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TW:

How many hours were you working in that fall semester of 2020?

[11:15]
VC:

Oh, nonstop. Nonstop to get it going, yeah. Once it was up and running, it was like a smooth
operation that was working a little bit like clockwork, and it was really good. But at the
beginning, getting it set up, it took about seven – it took me seven weeks to get it started. It’s not
just me. I keep saying me. But it’s a large group of people, you know, getting this going. But it
took seven weeks, and I worked nonstop all the time for that seven weeks to get it going.

TW:

So, who did you report the results to? I mean, obviously the individual. But were there other
entities at the university, Public Health?

VC:

No, we had to report all positive results to Public Health, so that got directed – so that wasn’t my
job. So there was somebody who worked on the Health Records side. His name was Jordan
Robertson. He also had a team of people, but it was his team that required to report those positive
results to Utah Public Health. And then we just collected – we reported to our university audience
and anybody who wanted to know in the county or the state disaggregated information, so
nobody’s information, but just our overall positivity in how many tests we were running.
So we would tell the State of Utah, and then we would tell USU how many tests we had run, how
many were positive. And this was every day. So this was a daily briefing of what we were seeing
in the lab. And then anything – when the Delta variant was starting to come up, with our testing
we wouldn’t be able to tell you for sure it was a Delta variant. But there was something in our
testing that could suspect that maybe some were Delta variants.
So we had to separate those and send them to Utah Public Health so they could sequence them
and determine if they were the variants or not. They wouldn’t tell us if they were. That
information didn’t get back to us. But we had to send them all the positives that had this certain
signature in the testing results so they could verify what kind of variant it was.

TW:

And the results, I mean, were you sending them to the COVID containment team so they could
work with the individuals on isolating and quarantine?

[13:21]
VC:

Yeah. So, technically, my actual role is I cannot give anybody’s personal information to anybody.
But I would tell Case Containment just so they would have a heads-up, “Hey, we had 50 positives
today, just so you know.” So the chain of command was I would tell Jordan, and then Jordan
would tell Case Containment and that whole team led by Alice Brew [?] and Cindy Gill. But then
I couldn’t tell them like, “These people are positive.”
I could say like, “You’re going to have 50 today,” or, “10 today” so they could sort of – because
their job started once we got the results that day. So they sort of learned – we did two runs a day,
so at midday I would tell them, “At this time we know we have 20 positives.” And then at the end
of the day I’d say, you have X many more, so they’d sort of plan their evenings. I think it’s not –
I don’t know, if you have 100 people to contact trace, it’s nice to know that in advance.

TW:

Did---and maybe you know this; maybe you don’t – did you receive any COVID federal
emergency funding that the university applied for?
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VC:

Yes, I believe so. So I believe the whole lab was funded by that. And I believe that my salary
came from that CARES money, is my understanding.

TW:

And did other Utah universities have the same capacity or ability to test their students?

VC:

So they did not. So Logan campus, I think just by virtue of the size and the facilities they had,
was the only place where we could do this molecular PCR-based testing. They did institute, I
think, some rapid clinics where they did the rapid antigen testing on different southern sites. But
they didn’t have the resources to set up this type of testing at each campus.

TW:

Okay. And did the Spanish Fork facility also run tests, or did it just happen up here in the Logan
campus?

VC:

It was just here at the Logan campus, hm-hmm.

[15:17]
TW:

Okay. So you had already talked about the level of staffing that you had. Did that change as time
went on, as we experienced the Delta variant in the second year of the pandemic?

VC:

We had a steady group of four testing technicians. But I think now they may have let some of
them go. I’m not sure what the current level is, because I don’t think they’re doing as much
testing as before. But at the time when I left – so I left in July 2021, at that time, and there were
still – I guess, no, we had the four.
Okay, we had access to four, but there were mainly two people working at that time. So two
people had found other jobs on campus. So, if we needed them in a pinch, they could come back.
But they had sort of other career aspirations that moved them somewhere else. But they were
there for backup. So, yeah, when I left, we were half-staffed but had the ability to bring two
people back if needed.

TW:

So in lay person’s terms, what is the process involved in running the test?
VC:
Okay, so let’s go from the beginning. So you feel sick. You need a test. So you go
somewhere, and either someone sticks a swab up your nose or you do it yourself. And then you
stick that in some solution that’s in a tube. And that solution is sterile until you put your dirty
swab in there. And there’s some sort of chemicals in there that keep the virus stable. So then now
that tube has to get to the lab. And when you get that tube to the lab, you have to store it in the
fridge, because your sample is pretty precious, and it needs to stay cold. So you have a
refrigerator that keeps all the samples.

[16:56]
And at that point, everything is double-bagged. So you have a swab in a tube in a bag in a bag,
because you need to make sure that nothing is going to spill, especially when it’s being
transported. So the biggest step now is just getting all the samples out and organized and keeping
all the staff safe. So you have to – each tube has a barcode, so this is how it’s linked to your
person. And so you have to carefully remove the tube, so you have to take off all the bags.
You have a tube with a barcode. You have to scan the barcode, and they have to put it in a rack.
And this rack has to correspond with how you’re going to transfer the samples into sort of the
testing material. So you have to be very organized to get it in the testing material. And somebody
USU COVID-19 2022: DR. VALERIE CROWLEY
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has to physically remove a bit of sample from your tube and put it in another tube. So this is the
slowest step. So you have – you do 96 at a time in a rectangular plate.
And so there’s a technician there who is removing one sample at a time, making sure you don’t
mess up the order, making sure you get it barcoded into the system, and without doing this in a
dangerous way. So you need to keep everybody clean and safe. And then from there your sample
is – and then you have some control samples. You want to make sure the run is running properly,
so you have some controls on there too. And then what you’re going to do is extract the nucleic
acid. So you hear that SARS-CoV-2 is an mRNA virus.
So you need to take the mRNA out. And so, in the swab, you have it all mixed with all of your
human cells, mucus, all the stuff that’s up your nose, but you want to isolate just the nucleic acid.
So you’re going to do that by adding some chemicals and using a robot that’s going to use
magnetic beads to essentially extract your RNA based on magnetic properties. So all the RNA
from the human and whatever virus or pathogens are there are going to get extracted. And then
you need to detect that virus.
[18:49]
But you can’t detect RNA directly. You have to do some reactions to convert that into DNA. So
now you do a bunch of reactions to all of the samples to convert the RNA into DNA, which is
another step. And now that you have the DNA, this is what you’re actually going to detect, and
what you hear people talk about is called PCR. And so now you’re going to use a number of
genes to make sure that – so we amplified three different genes from the SARS-CoV-2 virus and
two controls, so each reaction has five things that you’re looking for.
And then now this is where you do PCR. So you take little pieces of DNA that are going to kneel
to the DNA in the sample. And if it’s positive, you’re going to get a signal. And if it’s negative,
you’re not going to get a signal. It’s all based on fluorescence, and you put it in a [queued ?] PCR
instrument, and then you put it into an algorithm that takes these five genes. Then it spits out
whether it’s a positive or a negative based on sort of criteria, some threshold criteria of positivity.
TW:

And did you have any false positives?

VC:

So you would never really know that. So you wouldn’t know that directly with the testing. You
do background testing on lots of samples. So you exchange samples with Utah Public Health, and
you exchange with labs to make sure – it’s called proficiency testing – to make sure that you’re
getting the results you expect. And our results always coincided with what you’re supposed to
get.
And you coincide – you do that with Public Health, and you do that with an external validation
company as well, Health Cap, the College for American Physicians. So it’s all blinded. You don’t
know what you’re getting. And you send the results to make sure that everything is matching, and
we matched. If you don’t match, you don’t get to keep running your tests. They shut you down.
Yeah.

TW:

You had talked about it a little bit. But with the different strands or mutations of the virus, did any
of the results and the way you ran the tests change suddenly? Or were they pretty much the same?

[20:51]
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VC:

Not really. So the only thing that happened for us to signal that maybe we had a variant – so we
looked at three genes in the genome of SARS-CoV-2. I don’t know how many genes it has. I’m
going to guess 30. I don’t really know. And so we know that the Delta variant, one of those
genes, called the S gene, is not going to amplify, because it’s too mutated compared to the wild
type.
So in our signals, two genes positive was a positive, but if the S gene was negative, we thought
maybe it was a variant. So that’s when that test would maybe go for sequencing. But it’s still a
positive. And the assay that we had is robust enough, based on the backgrounds, that it’s going to
catch almost everything, unless all three genes are highly mutated and it doesn’t work, which is a
much more rare situation that we haven’t encountered yet.

TW:

And how many total tests did you perform in your time?

VC:

So I think the grant was about 12,000, maybe, when I left, something like that. And these were all
done by hand, so if you were in a big hospital, they’d have a robot that would do pretty much –
you would just have to move a plate between robots. But we didn’t – we had one robot that
extracted the RNA. But everything else was done by hand. So it was a very manual process for
the technicians to do.

TW:

So, when you were fully up and running, were there any other challenges, especially the latter
part – let’s say spring semester of 2021 before you left – that were things that you hadn’t
accounted for or didn’t expect? Or –

[22:39]
VC:

There’s always issues when you run a lab. [Laughs] There’s always stuff. Nothing was major that
we couldn’t solve the problem and keep the lab going. I was on mat leave for three months at one
point. So I guess that was January to March of 2021. And there was somebody who filled in for
me. And I know that, at that time, there was a contamination issue that they couldn’t figure out
what happened, so the lab had to close for a week or two.
They resolved that by just getting the instruments deep-cleaned, I think, from the providers. But,
labs, there’s human error. There’s mechanical errors. There is errors in shipments and lot
numbers. There’s lots of moving parts, but it was everything that we could pretty much solve, and
things that I’ve encountered before. I’ve worked in labs as a molecular biologist for my whole
professional life. So they’re things that I had always seen before. So it was easy to fix.

TW:

So, do you have any memorable events during your time running the COVID testing lab that
you’d like to share?

VC:

See, I feel very – I don’t know, I had a very – I felt very happy when we started. It was seven
weeks of just getting things up and going. And then, you know, we then did a dry run of the
whole process. So, as an experimental scientist, I like to do pilots. And you test everything out
before you do the full rollout. And when we did the full thing, like we had people go, and like I
think it was maybe John Cockett and Frank Galey pretending to have COVID and going to the
sampling site and getting tested and having the whole thing go through the information system,
bring it to the technicians, and do the whole thing.
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I always found it really exciting, because it worked the first time through. And so I feel like that
was such a big, exciting moment that we were actually going to get this going relatively quickly.
But I don’t know, it was a really – so, working at the UVDL, everybody was so kind and
welcoming. They didn’t know me and I didn’t know them, and I’d just sort of come in there, and
we’d bring a whole bunch of people around and get in their space. But everybody was so
welcoming.
[24:51]
But there was also a lot of fear about what this virus was doing and how it was re – at that point
we knew it was transmitted by air, but we didn’t – you know, people are still sterilizing their cans
of food from the supermarket some places. And some people didn’t want to acknowledge that it
existed at all. So it was a weird time, sort of, not necessarily with the lab, but just sort of living in
that time, which we all lived in this weird time together.
Actually, I think the most memorable thing about the pandemic was before I started at the
COVID lab when I was at the Human Research Protection Program the week before the
university shut down. So I guess it went remote on March 13. But a day or two before, we were
all sitting around a big conference table in my boss’s office. And we had the Johns Hopkins, you
know, COVID counter thing with like the red dots looking like a radar on this giant Apple screen
on a computer like on the table.
And it felt like we were in a horror movie, because we’re just sitting there and looking at these
numbers. And it’s like, “Is it really something to worry about? Is it not?” And I guess they had
just called it a pandemic a few days earlier, and we were just sort of all in sort of shock of like,
“Why are we still working in the office?” And I don’t know, I think that was the biggest moment
of the pandemic, just sort of sitting there altogether looking at the screen counting numbers of
infected people. So it was just a scary time to be living through for everybody.
TGRW: So you had touched upon it a little bit. And it seems like, once you got your kind of like purpose,
which is putting together – get this lab up and running, you felt like, “Yeah, I’m doing
something.” What was the relationship – how did John Cockett support the testing lab and the
testing center?
[26:46]
VC:

So my understanding is that he is – I guess I don’t know the official title of his role, but he’s like
the director of maybe IT at the Sorenson Center for Clinical Excellence, maybe is what it’s called.
And so they deal with personal protective health information because of the clinical services that
they offer. I don’t know all the services they offer, but they do at least offer, I think,
psychological services to the community, if not students, also to the community. I’m not entirely
sure.
But because he oversees that part, he needed to be involved in how to get, you know, all the
backend IT stuff ready for all of this, because we were using the electronic health record program
that they were using. It’s a program called P&C, Point and Click. And so there’s all this backend
stuff of – it’s actually much more complicated than setting up the lab, is getting all the IT stuff
going in the background, where it has to go in a way where we can get our results, because an
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algorithm spits it out in a certain way, so then they have to take that data, get it into the health
records.
And it has to get approved by the nurse practitioner who is overseeing all the testing. And then it
has to go into the patient records. And all of this is also very highly regulated. So, since they had
experience with that, that’s how John Cockett on his team got involved in all of this.
TGRW: So you spoke of the welcoming environment when you first began. As you settled into your role,
how much pressure did you feel there was on the lab? And how did you and your team kind of
cope with the stressful environment you were under?
[28:28]
VC:

So I felt under a tremendous amount of pressure to get this thing going. And I would have
nightmares, like actual nightmares at night, that we would do something wrong and then the
newspaper would find out, and then it would be all this – you know, newspaper was like, “USU
testing lab misdiagnoses thousands of patients,” and all this. So I had those little fears. But at the
same time, I was so con – like I’ve done this so many times in my life that I wasn’t actually that
nervous about the actual practicalities of running the lab. Like I’ve done this before. It hasn’t
been under such a high-stake situation before.
But I did have a responsibility to make sure we’re testing and testing well. And I think there’s
something to be said about having a turnaround time that’s better than the hospitals, making sure
that the results are accurate, being confident about what you’re telling people, because there’s lots
of downstream effects for this. If you give somebody the wrong results – if, say, where they were
positive and you said they weren’t – they’re going and affecting a whole bunch of other people.
And if somebody was negative and you said they were positive, someone’s quarantining, missing
school and work, isolating from their families, if they’re following protocol.
So I felt that it had very serious consequences if you got it wrong. But the technique is a very
sound molecular biology technique that is – there’s not many doubts there. And, I mean, you can
do it badly and give people bad data. But we had everything in place, and we were also – so I was
technically what is called the technical supervisor for this lab. But there’s a person above called
the lab director. So the lab director is also involved at every point to make sure. And his name is
on our license.
So he is the one who has to make sure – like he’s ultimately responsible for all the stuff that
comes out of the lab. But, really, he was remote, and I felt that it was on me to do that properly.
And, as a scientist, you have to make sure the data is good. And so I wasn’t that worried. I was
just worried mainly that, you know, all the little bugs and not having it – turnaround time very
quickly. But it was okay. But, before it was started, it was much more pressure, because there’s
the question of, “When is it going to go? When is it going to go? When is it going to start? When
is it going to start?”

[30:35]
And it’s not going to happen overnight. So I was always very realistic in the sense that I never
told anybody what day we would start, because there’s no way to know when we’d be able to
start. But we could start seven weeks after, after we started doing it. So I was quite happy about
that. I thought it was quite an accomplishment to get that going. So many moving parts, hm-hmm.
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That was exciting too, right? Like there was a pandemic. We needed somebody to do this. It was
exciting. I thought it was very exciting. [Laughs]
TGRW: So you said you left in July of 2021. What happened? So what was the main factor in that
decision, and who took over your position? And what happened with the lab after?
VC:

Sure. So my husband got a job back in Toronto. So, as an academic you have to kind of go where
the academic jobs are, and so he got a job back in Toronto. This is where we’re from. So it’s hard
to not go home, especially after a pandemic and with a new baby. The desire to go home is very
strong. So I really, really enjoyed this job running this lab. And I really like the UVDL. But we
had to decide for ourselves and for our family that we needed to move home.
But we probably knew this in June. Or, no, when is Memorial Day? May? May, so we knew
Memorial Day weekend that he got this job offer. So then I immediately – so then we need to find
a replacement, or else the lab will shut down. So, luckily, there’s a woman, Michelle Mendenhall,
who was working in the Virology Department or lab, who we strong-armed, really, to – she’s
wonderful. She’s fully experienced to do this work. I don’t think she really wanted to do it, to be
honest.

[32:30]
And so I think the upper administration applied quite a bit of pressure on her to keep it going,
because there’s not that many people around that filled the qualifications. And so I think she was
very gracious in accepting it. But I think she may have been very pressured to do it. And I hope
it’s been okay for her. We’ve been in a little bit of contact once I immediately left, and it seemed
okay. But I hope that things have been going well for her. I’m always curious. I don’t want to
contact her and be like, “How’s it going?” But I’m always kind of curious to know how it’s
going. [Laughs]
TGRW: So, I mean, you’ve spoken to the difficulty of you getting everything set up, running the lab. So,
now that you’ve had some time away from it, what have been the most significant lessons you’ve
learned personally, professionally?
VC:

That, actually, the stuff I do in the lab that usually nobody cares about has a real-life application.
[Laughs] I mean, I’ve spent my whole life in a lab. Nobody cares about what I do. And then,
suddenly, I was like, “Oh, my skills are actually quite useful sometimes when there’s a pandemic
every 100 years.” So I felt very professionally well-positioned in a way and then quite – I don’t
know – professionally proud that that’s what I did and I could do and actually be useful.
And it also feels like a nice time to be a molecular biologist, because people talk about mRNA
vaccines, and then people are like, “What’s mRNA, Val? Tell us what this is.” And people are
quite curious, and it’s things that people never spoke about, you know, two years ago. Or just
talking about how different vaccines are made – like nobody cared about how your chickenpox
vaccine was made. But now everybody compares brands and talks about the technologies and
wants, you know, me to explain these things. So that much I find quite nice.

[34:20]
So it’s been – it’s also nice that we have vaccines and we can all sort of, you know, relax a little
bit. But I remember getting that first vaccine, because they put me in the early category to get
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vaccinated. So I got vaccinated in January of 2021. And just crying about getting that first
vaccine, and then getting the second shot, wow. Because going in there was lots of colleagues
that I had worked with doing this job. And everybody was like happy. And people were together.
You know, like people were congregated in a building at the Health Department to get a vaccine.
And there was kind of this joy sort of emanating from people in a way that I hadn’t seen in two –
you know, a year and a half at that point, or a year. And it felt so good to see people together and
happy. And like being the nerdy molecular biologist, be like, “Molecular biology has saved the
day,” with these vaccines. And so it was very, very emotional, and I cried getting these vaccines,
because it was so – you know, it lifted a lot of weight off of the shoulders. I don’t even remember
what your question was anymore, Tameron. [Laughs]
TGRW: Right.
TW:

So is there anything else you’d like to add about your experiences during the COVID pandemic?

VC:

I just want to thank the people that trusted me to get this part of the story going. So, you know, I
sent a generic email to an email box, and people had to put a lot of faith in me that I could
actually do what I said, because nobody knew that I could do this. And so I feel very appreciative
that people were like, “Sure, like let’s give this woman a chance to do this.” But I think they had
no choice. [Laughs] But it was a really positive experience, I think.

[36:09]
Even though it was stressful, it was still very exciting. There were too many meetings, way too
many meetings, people wanting to meet all the time and updates. But it felt – but it was nice to
see everybody come together. I met people I never would have met, interacting with the president
and John Cockett every day, talking – you know, having Frank Galey call me at 7:00 in the
morning, you know, these kinds of things that would never have happened. So it was quite nice. It
was sad to leave.
I think these, you know, obstacles bring people close together, and it was a stressful, scary time.
And it was really, really fun to work with everybody. And to see everybody doing their job so
well and just getting things done was a really great experience, you know, especially at a time
that was really so bad for everybody at the same time. It was professionally quite great. I feel like
I lucked out professionally at this time to have a nice experience.
TW:

Well, Dr. Crowley, I’d like to thank you for taking this time this morning to discuss your
experience with the COVID pandemic at USU.

VC:

Thanks.

[End recording – 37:14]
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